Cytokine levels in breast cancer are highly dependent on cytomegalovirus (CMV) status
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Cytokine levels in breast cancer are highly dependent on cytomegalovirus (CMV) status ; volume:208 ; number:3 ; day:22 ; month:8 ; year:2024 ; pages:631-641 ; date:12.2024
Breast cancer research and treatment ; 208, Heft 3 (22.8.2024), 631-641, 12.2024
- Creator
-
Spencer, Juliet V.
Liu, Jianfang
Deyarmin, Brenda
Hu, Hai
Shriver, Craig D.
Somiari, Stella
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10549-024-07459-8
- URN
-
urn:nbn:de:101:1-2501182107475.193279384485
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Spencer, Juliet V.
- Liu, Jianfang
- Deyarmin, Brenda
- Hu, Hai
- Shriver, Craig D.
- Somiari, Stella
- SpringerLink (Online service)
Other Objects (12)
Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies
Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors
Targeting cytomegalovirus (CMV) antigens for GBM immunotherapy
Human cytomegalovirus (CMV) dysregulates neurodevelopmental pathways in cerebral organoids
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events
Detection of cytomegalovirus (CMV) by digital PCR in stool samples for the non-invasive diagnosis of CMV gastroenteritis
Correction to: Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events
Genetically engineered live-attenuated cytomegalovirus (CMV) vaccines improve pregnancy outcome in the guinea-pig model of congenital CMV infection
Kinetics of IgG antibody to cytomegalovirus (CMV) after birth and seroprevalence of anti-CMV IgG in Chinese children
A cytomegalovirus inflammasome inhibitor reduces proinflammatory cytokine release and pyroptosis
Cytomegalovirus (CMV) seroprevalence among women at childbearing age, maternal and congenital CMV infection: policy implications of a descriptive, retrospective, community-based study
Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies
Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors
Targeting cytomegalovirus (CMV) antigens for GBM immunotherapy
Human cytomegalovirus (CMV) dysregulates neurodevelopmental pathways in cerebral organoids
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events
Detection of cytomegalovirus (CMV) by digital PCR in stool samples for the non-invasive diagnosis of CMV gastroenteritis
Correction to: Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events
Genetically engineered live-attenuated cytomegalovirus (CMV) vaccines improve pregnancy outcome in the guinea-pig model of congenital CMV infection
Kinetics of IgG antibody to cytomegalovirus (CMV) after birth and seroprevalence of anti-CMV IgG in Chinese children
A cytomegalovirus inflammasome inhibitor reduces proinflammatory cytokine release and pyroptosis
Cytomegalovirus (CMV) seroprevalence among women at childbearing age, maternal and congenital CMV infection: policy implications of a descriptive, retrospective, community-based study
Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies
Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors
Targeting cytomegalovirus (CMV) antigens for GBM immunotherapy
Human cytomegalovirus (CMV) dysregulates neurodevelopmental pathways in cerebral organoids
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events
Detection of cytomegalovirus (CMV) by digital PCR in stool samples for the non-invasive diagnosis of CMV gastroenteritis
Correction to: Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events
Genetically engineered live-attenuated cytomegalovirus (CMV) vaccines improve pregnancy outcome in the guinea-pig model of congenital CMV infection
Kinetics of IgG antibody to cytomegalovirus (CMV) after birth and seroprevalence of anti-CMV IgG in Chinese children
A cytomegalovirus inflammasome inhibitor reduces proinflammatory cytokine release and pyroptosis